Agilent Technologies, Inc. - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
A New York 8081 www.agilent.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Agilent Technologies, Inc.

Avantor Stock Surged Because One Segment Stopped Shrinking - Jul 30th, 2026 12:29 pm
Revvity to Report Q2 Earnings: What's in Store for the Stock? - Jul 30th, 2026 10:40 am
Philips Q2 Earnings and Revenues Increase Year over Year, Shares Down - Jul 29th, 2026 12:01 pm
Is Argenx (ARGX) Outperforming Other Medical Stocks This Year? - Jul 29th, 2026 7:40 am
Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo - Jul 29th, 2026 6:00 am
Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26 - Jul 28th, 2026 2:15 pm
[Latest] Global Precision Diagnostics And Medicine Market Size/Share Worth USD 345.75 Billion by 2035 at a 8.91% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) - Jul 28th, 2026 11:30 am
Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders - Jul 27th, 2026 7:01 am
DXCM Q2 Results Likely to Reflect Strong G7 & Reimbursement Expansion - Jul 27th, 2026 7:00 am
Is Agilent Technologies (A) Undervalued Following Its FDA Approval For OPDIVO Companion Diagnostics? - Jul 25th, 2026 3:16 pm
Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test - Jul 25th, 2026 9:12 am
What to Expect From Agilent Technologies' Q3 2026 Earnings Report - Jul 24th, 2026 9:39 am
Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds? - Jul 24th, 2026 9:24 am
Will Baxter's Q2 Results Continue to Reflect Operational Headwinds? - Jul 24th, 2026 9:21 am
1 Healthcare Stock to Research Further and 2 We Avoid - Jul 24th, 2026 6:49 am
Reading Between The Lines Of DHR's Latest Call - Jul 24th, 2026 6:23 am
In Vitro Toxicology Testing Market to Exceed $20.97 Billion by 2031 as Non-Animal Testing & AI Adoption Accelerate - Analysis by Product, Toxicity Endpoints & Type, Technology, Method, Service, Region - Jul 23rd, 2026 8:09 am
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma - Jul 23rd, 2026 6:00 am
Agilent Increases Its Investment in HALO X-ray Technologies - Jul 20th, 2026 1:11 am
Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate - Jul 17th, 2026 4:44 am